Companies › ABEO
ABEONA THERAPEUTICS INC (ABEO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000318306 · EDGAR filings · Updated 2026-07-22
ABEONA THERAPEUTICS INC (ABEO) has reported institutional ownership of 69.3%, with 107 institutional managers holding positions valued at $177.1M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-22 — Insider transaction reported (Form 4)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-10 — Prospectus supplement (424B3) filed
- 2026-07-09 — Insider transaction reported (Form 4)
- 2026-07-09 — Insider transaction reported (Form 4)
- 2026-07-09 — Insider transaction reported (Form 4)
- 2026-07-09 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ABEONA THERAPEUTICS INC has 107 institutional holders and institutional ownership of 69.3%.
Insider activity
Insiders reported 49 transactions (0 buys, 35 sells) across 12 reporting insiders, with a net reported value of −$3.37M.
Data flags from SEC filings
Related companies
SIGA TECHNOLOGIES INC (SIGA) · USANA HEALTH SCIENCES INC (USNA) · ANIKA THERAPEUTICS INC (ANIK) · LINEAGE CELL THERAPEUTICS IN (LCTX) · CAMP4 THERAPEUTICS CORP (CAMP) · ORASURE TECHNOLOGIES INC (OSUR)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-22.